Baroness Blake of Leeds

I thank the noble Lord for his comments. It is still worth raising these matters in this context to avoid any confusion. Amendment 162, tabled by the noble Lord, Lord Shinkwin, wo…

My Lords, I thank all noble Lords who have contributed to this very important debate. As usual, I will limit my comments to amendments on which the Government have major legal, te…

I would be happy to write to the noble Baronesses with clarification on that point; I thank them for their interventions. As I was saying, Amendment 713A appears to introduce a pa…

Apologies; I thank the noble Baroness for her clarification on that point. I was mid-sentence, so forgive me if I repeat myself. Limiting the number of manufacturers based on prio…

I hope that noble Lords can listen to what I have to say. The clinical trial processes for approved substances are, of course, an essential part as we move forward. Amendment 703,…

I do not think it would be appropriate to comment on that level of detail at this point.

I just reinforce to the noble Lord that it would be completely wrong to pre-empt the decisions of Parliament—I am sure he is fully aware of that. I just want to give reassurance t…

As always, my noble friend raises an important point. I will go on to talk about the whole issue of substances, so if I do not address the points he raised, I will be happy to spe…

I completely recognise the noble Lord’s strength of feeling, which he has expressed on many occasions. However, I just reaffirm that we would go through a process for determining…

I can only refer the noble Lord to previous comments that the details around these matters will be considered when progress is made. It is not appropriate for those matters of det…

My Lords, I thank all noble Lords for taking part in the debate so far today. As we know, this group of amendments focuses on two core subjects: first, adding a new multidisciplin…